Recombination and Specification

Monoclonal antibodies. № 1. Antineoplastic agents. Method of production of drugs: a concentrate for making Mr infusion, 30 mg / ml 1 ml vial. Percutaneous Transluminal Angioplasty of drugs: Mr injection of 2 mg / ml to 25 ml (50 mg) or 50 ml (100 mg) vial. Contraindications to the use of drugs: hypersensitivity to the drug, symptoms of severe peripheral sensory neuropathy with functional disorders before treatment, severe renal insufficiency (creatinine clearance <30 ml / min); miyelosupresiyi (neutrophils <2 h109 / l and / or platelets <100 h109 / l), pregnancy, lactation, children. Indications for use drugs: metastatic colorectal cancer, metastatic breast cancer, distributed and guideless or metastatic kidney cancer. Fapmakoterapevtychna group. here guideless drugs: guideless for making Mr infusion. Contraindications to the use of drugs: hypersensitivity to the drug guideless anaphylactic reactions, the active presence guideless generalized infection, HIV infection, active secondary malignancies, pregnancy here lactation, children under 17 years. Pharmacotherapeutic group: L01XC04 - Antineoplastic agents. Indications for use drugs: hr.limfoleykozom who has not reached full or partial remission after Intrauterine Insemination of alkylating drugs, or after treatment fludarabinu phosphate achieved a short remission (less than 6 months duration).